Third-generation EGFR-TKI, Targeting EGFR m NSCLC with EGFR Ex19Del/L858R mutations, Inhibits CNS metastasis,
Sale!
Lucius
Replica Osimertinib EGFR m NSCLC Targeted Therapy
Original price was: $697.00.$538.00Current price is: $538.00.
Third-generation EGFR-TKI, Targeting EGFR m NSCLC with EGFR Ex19Del/L858R mutations, Inhibits CNS metastasis,
Reviews
There are no reviews yet.